Caisse Des Depots ET Consignations Grows Stock Position in Kenvue Inc. $KVUE

Key Points

• Caisse Des Depots ET Consignations increased its stake in Kenvue by 31.4% in Q4, buying 76,015 shares to hold 318,100 shares valued at about $5.49 million.
• Analysts have trimmed targets and ratings recently, leaving Kenvue with an average consensus rating of "Hold" and an average price target of $19.33.
• Kenvue announced a quarterly dividend of $0.2075 (annualized $0.83), implying a 4.8% yield

Caisse Des Depots ET Consignations boosted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 31.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 318,100 shares of the company's stock after buying an additional 76,015 shares during the period. Caisse Des Depots ET Consignations' holdings in Kenvue were worth $5,487,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of KVUE. Salomon & Ludwin LLC purchased a new stake in Kenvue during the 3rd quarter valued at $25,000. NBT Bank N A NY increased its stake in Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company's stock worth $25,000 after purchasing an additional 1,006 shares during the period. Cornerstone Planning Group LLC increased its stake in Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company's stock worth $25,000 after purchasing an additional 1,361 shares during the period. Physician Wealth Advisors Inc. increased its stake in Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company's stock worth $26,000 after purchasing an additional 618 shares during the period. Finally, Golden State Wealth Management LLC increased its stake in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company's stock worth $32,000 after purchasing an additional 1,190 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of recent analyst reports. Barclays reduced their target price on Kenvue from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 14th. Citigroup reduced their target price on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 15th. UBS Group reduced their target price on Kenvue from $19.00 to $18.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 7th. Jefferies Financial Group lowered Kenvue from a "buy" rating to a "hold" rating and reduced their target price for the stock from $23.00 to $18.00 in a research note on Friday, January 30th. Finally, Argus upgraded Kenvue to a "hold" rating in a research note on Friday, March 6th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. According to data from MarketBeat, Kenvue currently has an average rating of "Hold" and an average price target of $19.33.

Kenvue Stock Performance

Shares of Kenvue stock opened at $17.44 on Friday. The firm has a market cap of $33.48 billion, a P/E ratio of 22.65, a P/E/G ratio of 3.98 and a beta of 0.61. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The stock's fifty day moving average price is $17.72 and its 200-day moving average price is $17.17.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business's revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.26 earnings per share. On average, equities research analysts expect that Kenvue Inc. will post 1.1 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be paid a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue's payout ratio is 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.